Talks
Medicare bridge program: GLP1
August 25, 2026
Foundayo titration
August 25, 2026
Foundayo benefits
August 25, 2026
Diabetes treatment with many indications
August 25, 2026
Metformin mandatory?
August 25, 2026
Deintensify hypoglycemia-prone agents
August 25, 2026
GLP1/GIP RA in CHF
August 25, 2026
SGLT2i in CHF
August 25, 2026
Comorbidity driven drug selection in DM
August 25, 2026
GLP1 RA over Insulin
August 25, 2026
Ultrasound in CKD
August 25, 2026
Iodinated Contrast in CKD?
August 25, 2026
SOUL study results
August 25, 2026
SOUL study design
August 25, 2026
Kidney outcomes: SGLT2i vs GLP1RA in DM
August 25, 2026
Infinity Study Take Away
August 25, 2026
Infinity Study findings part 2
August 25, 2026
Infinity Study Findings part 1
August 25, 2026
Infinity Study Methods
August 25, 2026
Infinity Study background
August 25, 2026
SGLT2 Inhibitors in Advanced CKD and DM
July 24, 2026
When to Refer to Nephrology Part 2
July 24, 2026
T2DM and Advanced CKD
July 24, 2026
When to Refer to Nephrology Part 1
July 24, 2026
Anemia of CKD
July 24, 2026
DKA Resolution Criteria
July 24, 2026
Statin Therapy in CKD for Patients on HD
July 24, 2026
Potassium Management in DKA
July 24, 2026
Secondary Prevention in CKD
July 24, 2026
CKD is Now a Statin-Eligible Condition
July 24, 2026
Transition From IV to SQ Insulin in DKA
July 24, 2026
Plant Based Diets in CKD
July 24, 2026
Fluid Resuscitation in DKA
July 24, 2026
HbA1c is Unreliable in Advanced CKD
July 24, 2026
Kidney Failure Risk Equation (KFRE)
July 24, 2026
DKA Precipitants & Early Management
July 24, 2026
Renal Denervation in CKD
July 24, 2026
DKA vs. HHS
July 24, 2026
DKA Diagnostic Triad
July 24, 2026
Hyperlipidemia in T2DM
July 24, 2026
SGLT2 Inhibitors in ADPKD: Not Yet
June 28, 2026
BP Target in CKD Keeps Dropping
June 28, 2026
CKD Screening in DM
June 28, 2026
SGLT2 Inhibitors Work Across All CKD
June 28, 2026
CKM Syndrome: Tiered Framework
June 28, 2026
GLP1-RAs & Cancer Risk
June 28, 2026
STOP-ACEi Trial: Don’t Stop RAS Inhibition
June 28, 2026
Orforglipron: Small Molecule GLP1-RA
June 28, 2026
Treatment Disparity in T2DM
June 28, 2026
Retatrutide
June 28, 2026
CGM for T2DM: Even Without Insulin?
June 28, 2026
CONFIDENCE Trial: 2 Drugs At Once
June 28, 2026
Semaglutide vs. Tirzepatide Regarding CV Impact
June 28, 2026
FIND-CKD Trial
June 28, 2026
ADA 2026 Standards Updates
June 28, 2026
INFINITY: Finerenone Reduces Mortality
June 28, 2026
Treat T2DM Based On Comorbidities
June 28, 2026
EMPA-KIDNEY Legacy Effect
June 28, 2026
SURMOUNT-1: Tirzepatide Prevents T2DM
June 28, 2026
SOUL Trial: Oral Semaglutide CV Benefit
June 28, 2026
Loading logo
Close button
Why are you reporting this TALK?